ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function

In Vitro Cellular and Developmental Biology - Animal

Volumn 35, Issue 4, 1999, Pages 183-189

  Ricci, M Stacey ^a   Toscano, Diane G ^a   Toscano Jr , William A ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

Cytochrome P450; Endometrium; Estrogen; Toxicity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 7 ETHOXYCOUMARIN DEETHYLASE; AROMATIC HYDROCARBON RECEPTOR; DEXAMETHASONE; DIOXIN; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; PROGESTERONE; STEROID RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; BINDING SITE; CELL PROLIFERATION; DISSOCIATION; ENDOMETRIUM CELL; FIBROBLAST; GROWTH REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLLUTION; STEROID BINDING; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MURINAE;

EID: 0032962922     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-999-0025-5     Document Type: Article

References (45)

1. Decensi, A.; Fontana, V.; Bruno, S.; Gustavino, C.; Gatteschi, B.; Costa, A. Effect of tamoxifen on endometrial proliferation. J. Clin. Oncol. 14:434-440; 1996.
2. Denison, M. S.; Fisher, J. M.; Whitlock, J. P., Jr. Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. J. Biol. Chem. 264:16478-16482; 1989.
3. DeVito, M. J.; Thomas, T.; Martin, E.; Umbreit, T. H.; Gallo, M. A. Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol. Appl. Pharmacol. 113:284-292; 1992.
4. Feil, P. D.; Clarke, C. L.; Satyaswaroop, P. G. Progesterone receptor structure and protease activity in primary human endometrial carcinoma. Cancer Res. 48:1143-1147; 1988.
5. Fisher, B.; Costantino, J. P.; Redmond, C. K.; Fisher, E. R.; Wickerham, D. L.; Cronin, W. M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 86:527-537; 1994.
6. Gierthy, J. F.; Lincoln, D. W. Inhibition of post confluent focus production in cultures of MCF-7 breast cancer cells by TCDD. Breast Cancer Res. Treat. 12:227-233; 1988.
7. Gottardis, M. M.; Robinson, S. P.; Satyaswaroop, P. G.; Jordan, V. C. Contrasting actions of tamoxifen on endometrial and breast tumor growth in athymic mouse. Cancer Res. 48:812-815; 1988.
8. Greenlee, W. F.; Poland, A. An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/J2 mice by phenobarbital, 3-methyl cholanthrene, and TCDD. J. Pharmacol. Exp. Ther. 205:596-605; 1978.
9. Harper, N.; Wang, X.; Liu, H.; Safe, S. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by Ah receptor agonists. Mol. Cell. Endocrinol, 104:47-55; 1994.
10. Harris, M.; Zarcarewski, T.; Safe, S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the nuclear estrogen receptor in MCF-7 human breast cells. Cancer Res. 50:3579-3584; 1990.
11. Hochner-Celnikier, D.; Greenfield, C.; Finci-Yeheskel, Z.; Milwidsky, A.; Gutman, A.; Goldman-Wohl, D.; Yagel, S.; Mayer, M. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells. Mol. Hum. Reprod. 3:1019-1027; 1997.
12. Hudson, L. G.; Shaikh, R.; Toscano, W. A., Jr.; Greenlee, W. F. Induction of 7-ethoxycoumarin O-deethylase activity in human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor, Biochem. Biophys. Res. Commun. 115:611-617; 1983.
13. Hung, Y.-C.; Satyaswaroop, P. G. The female reproductive system: cell lines from tumors of the human ovary and uterus. In: Hay, R. J.; Park, J.-G.; Gazdar, A., ed. Atlas of human tumor cell lines. San Diego: Academic Press; 1994:359-386.
14. Katzenellenbogen, B. S.; Norman, M. J.; Eckert, R. L.; Peltz, S. W.; Mangel, W. F. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 44:112-119; 1984.
15. Kharat, I.; Saatcioglu, F. Antiestrogenic effects of TCDD are mediated by direct transcriptional interference with the liganded estrogen receptor. J. Biol. Chem. 271:10533-10537; 1996.
16. Krishnan, V.; Porter, W.; Santostefano, M.; Wang, X.; Safe, S. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-TCDD in MCF-7 cells. Mol. Cell. Biol. 15:6710-6719; 1995.
17. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T-4. Nature (Lond.) 227:680-685; 1970.
18. Matsushita, N.; Sogawa, K.; Ema, M.; Yoshida, A.; Fujii-Kuriyama, Y. A factor binding to the xenobiotic response element (XRE) of P4501A1 gene consists of at least two helix-loop-helix proteins, Ah receptor and Arnt. J. Biol. Chem. 268:21002-21006; 1993.
19. Mattick, S.; Glenn, K.; deHaan, G.; Shapiro, D. J. Analysis of ligand dependence and hormone response element synergy in transcription by estrogen receptor. J. Steroid Biochem. Mol. Biol. 60:285-294; 1997.
20. Moore, M.; Narasimhan, T. R.; Wang, X.; Krishnan, V.; Safe, S.; Williams, H. J.; Scott, A. I. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate (TPA) and 17β-estradiol in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 44:251-261; 1993.
21. Nodland, K. I.; Wormke, M.; Safe, S. Inhibition of estrogen-induced activity by 2,3,7,8-TCDD in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs. Arch. Biochem. Biophys. 338:67-72; 1997.
22. Ojeda, S. R. Female reproductive function. In: Griffen, J. E.; Ojeda, S. R., ed. Textbook of endocrine physiology. London: Oxford University Press; 1992:134-168.
23. Peterson, G. L. A simplification of the protein assay method of Lowry et al. which is generally more applicable. Anal. Biochem. 83:346-356; 1977.
24. Peterson, R. E.; Theobold, H. M.; Kimmel, G. L. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparison. CRC Crit. Rev. Toxicol. 23:283-335; 1993.
25. Poland, A.; Glover, E. Variation in the molecular mass of the Ah receptor among vertebrate species and strains of rats. Biochem. Biophys. Res. Commun. 146:1439-1449; 1987.
26. Poland, A.; Knutson, J. C. TCDD and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:517-554; 1982.
27. Reyes, H.; Reisz-Porzasz, S.; Hankinson, O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science (Wash., DC) 256:1193-1195; 1992.
28. Rheinwald, J. G. Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells. In: Baserga, R., ed. Cell growth and division: a practical approach. New York: IRL Press; 1989:81-94.
29. Rier, S. E.; Martin, D. C.; Bowman, R. E.; Dmowski, W. P.; Berker, J. L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 21:433-441; 1993.
30. Rodgers, N. T.; Kaufman, D. G. The measurement of cytosolic estrogen receptors in human endometrial tissue and organ cultures. J. Steroid Biochem. Mol. Biol. 14:801-806; 1981.
31. Rodriquez, J.; Sen, K. K.; Menon, M.; Johnson, T. R., Jr.; Menon, K. M. J. Progesterone binding by human endometrial tissue during the proliferative and secretory phases of the menstrual cycle and by hyperplastic and carcinomatus endometrium. Am. J. Obstet. Gynecol. 133:660-665; 1979.
32. Saceda, M.; Lippman, M. E.; Chambon, P.; Lindsey, R. L.; Ponglikitmongkol, M.; Puente, M.; Martin, M. B. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 2:1157-1162; 1988.
33. Safe, S. H. Modulation of gene expression and endocrine response pathways by 2,3,7,8-TCDD and related compounds. Pharmacol. Ther. 67:247-281; 1995.
34. Satyaswaroop, P. G.; Sivarajah, A.; Zaino, R. J. Hormonal control of growth of human endometrial carcinoma in nude mouse model. In: Brescani, F.; King, R. G. B.; Lippman, M. E., ed. Progress in cancer research and therapy. New York: Raven Press; 1988:430-435.
35. Satyaswaroop, P. G.; Tabibzadeh, S. S. Extracellular matrix and the patterns of differentiation of human endometrial carcinomas in vitro and in vivo. Cancer Res. 51:5661-5666; 1991.
36. Satyaswaroop, P. G.; Zaino, R. J.; Mortel, R. Human endometrial adenocarcinoma transplanted into nude mice: growth regulation by estradiol. Science (Wash., DC) 219:58-60; 1983b.
37. Satyaswaroop, P. G.; Zaino, R. J.; Mortel, R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res. 44:4006-4010; 1983a.
38. Schmidt, J. V.; Bradfield, C. A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12:55-89; 1996.
39. Soto, A. M.; Lin, T.-M.; Justica, H.; Silvia, R. M.; Sonnenschein, C. An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-Screen). In: Colborn, T.; Clement, C., ed. Adv. Mod. Environ. Toxicol. Princeton, NJ: Princeton Scientific Publishing Co.; 1992:295-309.
40. Soule, H. D.; Vasquez, J.; Long, A.; Albert, S.; Brennan, M. J. A human cell line from a pleural effusion derived from a breast cancer. J. Natl. Cancer Inst. 51:1409-1413; 1973.
41. Ullrich, V.; Weber, P. The O-dealkylation of 7-ethoxycoumarin by liver microsomes: a direct fluorimetric test. Hoppe-Seyler's Z. Physiol. Chem. 353:1171-1177; 1972.
42. van Zoelen, E. J. J.; Delaey, B.; van der Berg, B.; Huylebroeck, D. Detection of polypeptide growth factors: applications of specific bioassays and PCR technology. In: McKay, I.; Leigh, I., ed. Growth factors: a practical approach. New York: IRL Press; 1993:13-34.
43. Wang, F.; Hoivik, D.; Pollenz, R.; Safe, S. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. Nucleic Acids Res. 26:3044-3052; 1998.
44. Ways, D. K.; Kukoly, C. A.; deVente, J.; Hooker, J. L.; Bryant, W. O.; Posekany, K. J.; Fletcher, D. J.; Cook, P. P.; Parker, P. J. MCF-7 breast cancer cells transfected with PKC-α exhibit altered expression of other PKC isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95:1906-1915; 1995.
45. Zacharewski, T. R.; Bondy, K. L.; McDonell, P.; Wu, Z. F. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17-β-estradiol-induced pS2 expression. Cancer Res. 54:2707-2713; 1994.